{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -2.816907, "regularMarketPrice": 0.138, "exchange": "PNK", "shortName": "INTELGENX TECHNOLOGIES CORPORAT", "longName": "IntelGenx Technologies Corp.", "messageBoardId": "finmb_30124036", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1169044200000, "priceHint": 4, "fiftyTwoWeekLowChange": 0.027999997, "fiftyTwoWeekLowChangePercent": 0.25454542, "fiftyTwoWeekRange": "0.11 - 0.37", "fiftyTwoWeekHighChange": -0.23200001, "fiftyTwoWeekHighChangePercent": -0.62702703, "fiftyTwoWeekLow": 0.11, "fiftyTwoWeekHigh": 0.37, "earningsTimestamp": 1683837000, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -0.07, "epsForward": 0.12, "sharesOutstanding": 174646000, "bookValue": -0.02, "fiftyDayAverage": 0.171, "fiftyDayAverageChange": -0.033000007, "fiftyDayAverageChangePercent": -0.1929825, "twoHundredDayAverage": 0.175, "twoHundredDayAverageChange": -0.037, "twoHundredDayAverageChangePercent": -0.21142858, "marketCap": 24101148, "forwardPE": 1.15, "priceToBook": -6.9, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.004000008, "regularMarketTime": 1684179600, "regularMarketDayHigh": 0.1425, "regularMarketDayRange": "0.13552 - 0.1425", "regularMarketDayLow": 0.13552, "regularMarketVolume": 45585, "regularMarketPreviousClose": 0.142, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.142, "averageDailyVolume3Month": 192576, "averageDailyVolume10Day": 79650, "trailingAnnualDividendYield": 0.0, "displayName": "IntelGenx", "symbol": "IGXT"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "6420 Abrams", "address2": "Ville Saint Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Y2", "country": "Canada", "phone": "514-331-7440", "fax": "514-331-0436", "website": "https://www.intelgenx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Andr\u00e9  Godin C.A., CPA, CA, CPA", "age": 58, "title": "Pres & CFO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 242066, "fmt": "242.07k", "longFmt": "242,066"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tommy  Kenny J.D., L.L.B., M.Sc.", "age": 35, "title": "Sr. VP & Gen. Counsel", "yearBorn": 1987, "fiscalYear": 2022, "totalPay": {"raw": 141205, "fmt": "141.21k", "longFmt": "141,205"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Nadine  Paiement", "age": 45, "title": "Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 151694, "fmt": "151.69k", "longFmt": "151,694"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dwight  Gorham", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Stephen  Kilmer", "title": "Investor Relations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David M. Kideckel M.B.A., MBA, Ph.D.", "age": 41, "title": "Sr. VP and Head of Corp. Devel. & Strategic", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ingrid  Zerbe", "age": 68, "title": "Corp. Sec.", "yearBorn": 1954, "fiscalYear": 2006, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}